EnQuest PLC: Nasdaq Stockholm delisting update
EnQuest PLC, 30 October 2023
EnQuest application to delist its shares from Nasdaq Stockholm - shareholder update
As notified in a previous announcement on 5 September 2023, EnQuest PLC ('EnQuest' or the 'Company') plans to apply for a delisting of the Company's shares from Nasdaq Stockholm. The formal request to delist is therefore expected to be submitted to Nasdaq Stockholm on 5 December with the last day of trading likely to be around two weeks after the application date (the "Delisting Date"). The Company's shares will remain listed on the London Stock Exchange.
In order to continue trading in EnQuest shares, EnQuest shareholders holding their shares through Euroclear Sweden AB must arrange for a cross-border transfer of their shares into the book-entry system maintained by Euroclear UK & Ireland Limited (also known as CREST).
DNB Markets, a part of DNB Bank ASA, Sweden Branch ('DNB Markets') acts as EnQuest's Issuing Agent and will coordinate the conversion process. Shareholders should in the first instance, however, discuss the cross-border transfer of shares with their respective nominee bank.
Cross-border transfer applications should be made within the period of action, defined as being 31 October to 13 December 2023, and transfers made through DNB will be completed free of any charges to individual shareholders and nominees. Shareholders that do not apply for the cross-border transfer within the period of action will not be able to trade in the Company's shares following the Delisting Date.A letter with cross-border instructions will be distributed to all directly registered shareholders and to all custodians by 1 November 2023.
The instruction letter explains the cross-border process and any actions to be taken by shareholders.
Cross-border settlement will be done on a weekly basis starting from 8 November until 13 December
Shareholders should contact their respective nominee banks or EnQuest's Issuing Agent, DNB Markets (email: emissioner@dnb.sephone: +4684734550), for more information.
The information was submitted for publication, through the agency of the contact persons set out below, at 14:00 UK time on 30 October 2023.
Ends
For further information please contact:
EnQuest PLC Tel: +44 (0)20 7925 4900
Amjad Bseisu (Chief Executive Officer)
Salman Malik (Chief Financial Officer)
Craig Baxter (Head of Investor Relations)
Teneo Tel: +44 (0)20 7353 4200
Martin Robinson
Martin Pengelley
Harry Cameron
Notes to editors
ENQUEST
EnQuest is providing creative solutions through the energy transition. As an independent energy company with operations in the UK North Sea and Malaysia, the Group's strategic vision is to be the partner of choice for the responsible management of existing energy assets, applying its core capabilities to create value through the transition.
EnQuest PLC trades on both the London Stock Exchange and the NASDAQ OMX Stockholm.
Please visit our website www.enquest.com for more information on our global operations.
Forward-looking statements: This announcement may contain certain forward-looking statements with respect to EnQuest's expectations and plans, strategy, management's objectives, future performance, production, reserves, costs, revenues and other trend information. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may occur in the future. There are a number of factors which could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. The statements have been made with reference to forecast price changes, economic conditions and the current regulatory environment. Nothing in this announcement should be construed as a profit forecast. Past share performance cannot be relied upon as a guide to future performance.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com orvisit www.rns.com.